Access
To read this story in full you will need to login or make a payment (see right).
Letter
Nature 439, 973-977 (23 February 2006) | doi:10.1038/nature04422; Received 10 August 2005; Accepted 11 November 2005; Published online 11 December 2005
Open Innovation Challenges
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
nature jobs
Thermo- Chemical Sciences
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
Two Post-Doctoral Position In Nanomedicine
- Fondazione IRCCS Istituto Neurologico "Carlo Besta" (FINCB)
- Via Celoria n.11, 20133 Milano, Italy
Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1
Davide Gabellini1, Giuseppe D'Antona2, Maurizio Moggio3, Alessandro Prelle3, Chiara Zecca3, Raffaella Adami2, Barbara Angeletti4,5, Patrizia Ciscato3, Maria Antonietta Pellegrino2, Roberto Bottinelli2, Michael R. Green1 & Rossella Tupler1,4,5
- Howard Hughes Medical Institute, Programs in Gene Function and Expression and Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA
- Dipartimento di Medicina Sperimentale, Sezione di Fisiologia umana, Università degli Studi di Pavia, 27100 Pavia, Italy
- U.O. Neurologia, Università degli Studi di Milano, I.R.C.C.S. Fondazione Ospedale Maggiore, 20122 Milano, Italy
- Biologia Generale e Genetica Medica, Università degli Studi di Pavia, 27100 Pavia, Italy
- †Present address: Dipartimento di Scienze Biomediche, Università degli Studi di Modena e Reggio Emilia, 41100 Modena, Italy
Correspondence to: Rossella Tupler1,4,5 Correspondence and requests for materials should be addressed to R.T. (Email: rossella.tupler@umassmed.edu).
Abstract
Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant neuromuscular disorder that is not due to a classical mutation within a protein-coding gene1, 2. Instead, almost all FSHD patients carry deletions of an integral number of tandem 3.3-kilobase repeat units, termed D4Z4, located on chromosome 4q35 (ref. 3). D4Z4 contains a transcriptional silencer whose deletion leads to inappropriate overexpression in FSHD skeletal muscle of 4q35 genes located upstream of D4Z4 (ref. 4). To identify the gene responsible for FSHD pathogenesis, we generated transgenic mice selectively overexpressing in skeletal muscle the 4q35 genes FRG1, FRG2 or ANT1. We find that FRG1 transgenic mice develop a muscular dystrophy with features characteristic of the human disease; by contrast, FRG2 and ANT1 transgenic mice seem normal. FRG1 is a nuclear protein and several lines of evidence suggest it is involved in pre-messenger RNA splicing5, 6, 7. We find that in muscle of FRG1 transgenic mice and FSHD patients, specific pre-mRNAs undergo aberrant alternative splicing. Collectively, our results suggest that FSHD results from inappropriate overexpression of FRG1 in skeletal muscle, which leads to abnormal alternative splicing of specific pre-mRNAs.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
A foundation for limb-girdle muscular dystrophyNature Medicine News and Views (01 May 1995)
RESEARCH
An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologiesThe EMBO Journal Article (22 Oct 2008)
Normal growth and regenerating ability of myoblasts from unaffected muscles of facioscapulohumeral muscular dystrophy patientsGene Therapy Research Article
See all 43 matches for Research
